Literature DB >> 24434452

Defining an Intermediate Step in End-of-Life Therapy.

Dan R Thompson1.   

Abstract

Mesh：

Year:  2014        PMID： 24434452     DOI： 10.1097/CCM.0b013e3182a63737

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  2 in total

1.  Respective impact of no escalation of treatment, withholding and withdrawal of life-sustaining treatment on ICU patients' prognosis: a multicenter study of the Outcomerea Research Group.

Authors:  Alexandre Lautrette; Maïté Garrouste-Orgeas; Pierre-Marie Bertrand; Dany Goldgran-Toledano; Samir Jamali; Virginie Laurent; Laurent Argaud; Carole Schwebel; Bruno Mourvillier; Michaël Darmon; Stéphane Ruckly; Anne-Sylvie Dumenil; Virginie Lemiale; Bertrand Souweine; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2015-07-07       Impact factor: 17.440

2.  "No escalation of treatment" as a routine strategy for decision-making in the ICU: pro.

Authors:  Dan R Thompson
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.